Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer

PURPOSE: Neoadjuvant chemotherapy (NAC) is less effective for luminal breast cancer because luminal breast cancer has a lower rate of pathological complete response (pCR) after NAC than human epidermal growth factor receptor 2 (HER2)-type and triple-negative breast cancer (TNBC). We investigated the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Breast Cancer
Main Authors: Kim, Hyung Suk, Yoo, Tae Kyung, Park, Woo Chan, Chae, Byung Joo
Format: Artigo
Sprog:Inglês
Udgivet: Korean Breast Cancer Society 2019
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6769389/
https://ncbi.nlm.nih.gov/pubmed/31598341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2019.22.e35
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker